~~<i id='CD3E2BFB33'><strike id='CD3E2BFB33'><tt id='CD3E2BFB33'><pre id='CD3E2BFB33'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：focus 2025-09-30 07:42:29 Page View：47

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

focus

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

1:29Rep.RubenGallego,D-Ariz.,holdsatownhallinBuckeye,Ariz.,Aug.6,ashecampaignsfortheU.S.Senate.ABCNe

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Democratic lawmaker calls for 'well

2:42InthisJune15,2022,filephoto,Rep.DeanPhillipsspeaksatanewsconferenceintheCapitolinWashington,D.C.